Alonso, who took his titles with Renault in 2005 and 2006, has not won a race since his 32nd career victory at Ferrari in 2013
The former head of the Malankara Mar Thoma Syrian Church and the longest-serving bishop in India Dr Philipose Mar Chrysostom died due to age-related ailments on Wednesday, a church spokesman said.
He was 103.
Mar Chrysostom was discharged from a hospital in Thiruvalla on Tuesday. He breathed his last at a private hospital in Kumbanad near here around 1.15 am, the spokesman said.
An outstanding religious dignitary with a genuine humanitarian outlook and global vision, Mar Chrysostom was awarded Padma Bhushan by President Ram Nath Kovind in 2018.
He is credited with implementing and formulating many projects to improve the social, economic and cultural condition of the poor and deprived.
Born on April 27, 1918 in Karthikappally, he had inherited the missionary zeal from his father.
After obtaining graduation from Union Christian (UC) College, Alwaye, he was attracted to missionary work and ordained as Deacon of the Church in 1944. Nine years later, in 1953, he was consecrated as Bishop.
Mar Chrysostom became the Metropolitan of the Malankara Mar Thoma Syrian Church in 1999.
He was a bishop for 68 years.
Known for his pleasant attitude, the bishop was unparalleled with his touching style of speech full of humorous statements.
Many books and documentaries have been published containing his humorous speeches and talks.
Alonso, who took his titles with Renault in 2005 and 2006, has not won a race since his 32nd career victory at Ferrari in 2013
The rise of 'slow quitting', 'wage theft' and more
Sharjah Art Foundation's ongoing exhibitions devoted to the radical works of Emily Karaka and Bouchra Khalili carry a powerful message for the fragmented contemporary world of today
They find Dubai to be a business-friendly destination
She talks about the doors of opportunities money opened up for her in the country
A deep dive into the question that keeps resurfacing, 'Do you love me?'
AI chatbots in therapy: Game changer or just a fad?